Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Chan

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
Annals of Hepatology|May 25, 2026
Beyond hazard ratios: interpreting trial endpoints and survival analysis in systemic therapy for hepatocellular carcinomaFederico Piñero, Stephen L Chan, Arndt Vogel
Asia-Pacific Journal of Clinical Oncology|February 28, 2014
Economic analysis of aprepitant-containing regimen to prevent chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Hong KongStephen L Chan, Jason Jen, Thomas Burke, et al.
Expert Opinion on Therapeutic Targets|April 26, 2015
Novel therapeutic targets and predictive markers for hepatocellular carcinomaStephen L Chan, Anthony W H Chan, Winnie Yeo
Future Oncology (London, England)|August 12, 2009
Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?Stephen L Chan, Anthony T C Chan, Winnie Yeo
Cancers|July 9, 2022
Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma?Choong-Kun Lee, Stephen L Chan, Hong Jae Chon
Current Oncology Reports|March 22, 2012
Management of hepatocellular carcinoma: beyond sorafenibStephen L Chan, Tony Mok, Brigette B Y Ma
Molecular Carcinogenesis|March 21, 2020
Contaminated and misidentified cell lines commonly use in cancer researchSiu Tim Cheung, Stephen L Chan, Kwok Wai Lo
Current Gene Therapy|December 25, 2014
Targeting angiogenic genes as a therapeutic approach for hepatocellular carcinomaChi Hang Wong, Cesar S C Wong, Stephen L Chan
Hepatic Oncology|October 30, 2025
Clinical management of liver cancer patients with immune checkpoint inhibitors treatmentJohnny C W Yau, Landon L Chan, Stephen L Chan
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|April 8, 2011
Stereotactic radiotherapy for hepatocellular carcinoma: report of a local single-centre experienceL C Chan, Samuel K W Chiu, Stephen L Chan
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Annals of Hepatology|May 25, 2026
Beyond hazard ratios: interpreting trial endpoints and survival analysis in systemic therapy for hepatocellular carcinomaFederico Piñero, Stephen L Chan, Arndt Vogel
Asia-Pacific Journal of Clinical Oncology|February 28, 2014
Economic analysis of aprepitant-containing regimen to prevent chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Hong KongStephen L Chan, Jason Jen, Thomas Burke, et al.
Expert Opinion on Therapeutic Targets|April 26, 2015
Novel therapeutic targets and predictive markers for hepatocellular carcinomaStephen L Chan, Anthony W H Chan, Winnie Yeo
Future Oncology (London, England)|August 12, 2009
Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?Stephen L Chan, Anthony T C Chan, Winnie Yeo
Cancers|July 9, 2022
Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma?Choong-Kun Lee, Stephen L Chan, Hong Jae Chon
Current Oncology Reports|March 22, 2012
Management of hepatocellular carcinoma: beyond sorafenibStephen L Chan, Tony Mok, Brigette B Y Ma
Molecular Carcinogenesis|March 21, 2020
Contaminated and misidentified cell lines commonly use in cancer researchSiu Tim Cheung, Stephen L Chan, Kwok Wai Lo
Current Gene Therapy|December 25, 2014
Targeting angiogenic genes as a therapeutic approach for hepatocellular carcinomaChi Hang Wong, Cesar S C Wong, Stephen L Chan
Hepatic Oncology|October 30, 2025
Clinical management of liver cancer patients with immune checkpoint inhibitors treatmentJohnny C W Yau, Landon L Chan, Stephen L Chan
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|April 8, 2011
Stereotactic radiotherapy for hepatocellular carcinoma: report of a local single-centre experienceL C Chan, Samuel K W Chiu, Stephen L Chan
Pageof 17